ArticleCancer science2009
Predictors of response to exemestane as primary endocrine therapy in estrogen receptor-positive breast cancer.
Hiroko Yamashita et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
22 papers cite it
this papertrialcites it